IGHE and Alzheimer disease: Some studies have shown that dynamic changes in serum IgE levels may reflect the way AD responds to treatment, while others have shown that there is only a weak relationship between serum IgE and continued disease severity after treatment, suggesting that serum IgE is not the most accurate biomarker of AD [25].